Cytodyn Inc
OTC:CYDY
Cytodyn Inc
Depreciation & Amortization
Cytodyn Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cytodyn Inc
OTC:CYDY
|
Depreciation & Amortization
-$40k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
38%
|
CAGR 10-Years
21%
|
|
Abbvie Inc
NYSE:ABBV
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cytodyn Inc's Depreciation & Amortization?
Depreciation & Amortization
-40k
USD
Based on the financial report for Nov 30, 2023, Cytodyn Inc's Depreciation & Amortization amounts to -40k USD.
What is Cytodyn Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
21%
Over the last year, the Depreciation & Amortization growth was 90%.